Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of primary ciliary dyskinesia with synthetic messenger RNA

Treatment of primary ciliary dyskinesia with synthetic messenger RNA

US Patent 11510997 · Granted Nov 29, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipid nanoparticle compositions and uses thereof2025
Lipid nanoparticle compositions and uses thereof2025
Lipid nanoparticle compositions and uses thereof2025
Lipid nanoparticle compositions and uses thereof2025
Polynucleotide compositions, related formulations, and methods of use thereof2025
Polynucleotide compositions, related formulations, and methods of use thereof2025
Polynucleotide compositions, related formulations, and methods of use thereof2025
Polynucleotide compositions, related formulations, and methods of use thereof2025
Lipid nanoparticle compositions and uses thereof2024
Lipid nanoparticle compositions and uses thereof2024
Lipid nanoparticle compositions and uses thereof2024
Lipid nanoparticle compositions and uses thereof2024